Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1986-4-1
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
E
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0196-0229
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:pagination
181-6
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:3912845-Advisory Committees, pubmed-meshheading:3912845-Animal Experimentation, pubmed-meshheading:3912845-Clinical Trials as Topic, pubmed-meshheading:3912845-DNA, Recombinant, pubmed-meshheading:3912845-Ethics, Medical, pubmed-meshheading:3912845-Ethics Committees, Research, pubmed-meshheading:3912845-Federal Government, pubmed-meshheading:3912845-Genes, pubmed-meshheading:3912845-Genetic Engineering, pubmed-meshheading:3912845-Government Regulation, pubmed-meshheading:3912845-Humans, pubmed-meshheading:3912845-Information Dissemination, pubmed-meshheading:3912845-National Institutes of Health (U.S.), pubmed-meshheading:3912845-Patient Selection, pubmed-meshheading:3912845-Research Subjects, pubmed-meshheading:3912845-Risk Assessment, pubmed-meshheading:3912845-United States
pubmed:year
1985
pubmed:articleTitle
Points to consider in the design and submission of human somatic cell gene therapy protocols.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study